Do we need early risk stratification after ST-elevation myocardial infarction?

Heart. 2021 Dec;107(23):1852-1853. doi: 10.1136/heartjnl-2021-320030. Epub 2021 Sep 20.

Peter McLeod^{1

2}, Philip D Adamson^{3

4}, Sean Coffey^{5

2}

¹ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand.
² Department of Cardiology, Southern District Health Board, Dunedin, New Zealand.
³ Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
⁴ British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.
⁵ Department of Medicine - HeartOtago, University of Otago Dunedin School of Medicine, Dunedin, New Zealand [email protected].

No abstract available

Keywords: biomarkers; echocardiography; myocardial infarction.

Publication types